Alkermes (United States)

Alkermes (United States)

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alkermes (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

48%


Total
Publications

482


Total Open
Publications

233


Total
Citations

14K


Open Access
Percentage

48%


Total
Publications

482


Total Open
Publications

233


Total
Citations

14K

Wikipedia

Website

download

Breakdown

23% 21% 4% 52%

Publisher Open

23%

Both

21%

Other Platform Open

4%

Closed

52%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530354045505560Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

28%OA Journal

OA Journal 28%

58

Hybrid 38%

78

No Guarantees 34%

71

Other Platform Open

Domain 84%

103

Institution 15%

18

Other Internet 14%

17

Public 1%

1

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
102
DOI
Other Internet
15
Europe PMC
Domain
7
King's College London - Research Portal
Institution
5
Washington University School of Medicine - Digital Commons@Becker
Institution
2
Unknown Repository
Other Internet
2
University of Limerick - University of Limerick Institutional Repository
Institution
2
iu.edu OAI-PMH Repository
Institution
2
Dr Steevens Hospital Library - Lenus, The Irish Health Repository
Institution
2
University of Michigan - Deep Blue
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share